Active, not recruitingPHASE1, PHASE2NCT03277638

Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM)

Studying Astrocytoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Case Comprehensive Cancer Center
Principal Investigator
Tiffany Hodges, MD, MD
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Intervention
Pembrolizumab at 7 days prior(drug)
Enrollment
32 enrolled
Eligibility
18 years · All sexes
Timeline
20172026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03277638 on ClinicalTrials.gov

Other trials for Astrocytoma

Additional recruiting or active studies for the same condition.

See all trials for Astrocytoma

← Back to all trials